This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Charlotte, NC-based Albemarle Corporation is a premier specialty chemicals company with leading positions in attractive end markets globally. It is a leading producer of highly-engineered specialty chemicals geared to meet customer requirements across a bevy of end markets including petroleum refining, consumer electronics, energy storage, construction and automotive.
Albemarle (ALB) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Albemarle (ALB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Albemarle (ALB) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Albemarle (ALB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why You Should Hold Onto Albemarle (ALB) Stock for Now
by Zacks Equity Research
Albemarle (ALB) to gain from strength in the lithium business and expansion actions.
Albemarle Expects Lithium Volume Shift to Hurt Q1 Results
by Zacks Equity Research
Albemarle (ALB) expects adjusted Q1 EPS in the range of $1.20-$1.25. However, the company has reaffirmed its full-year guidance.
Why Is Albemarle (ALB) Down 4.2% Since Last Earnings Report?
by Zacks Equity Research
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Chemical Diversified Stock Outlook: Near-Term Prospects Dim
by Anindya Barman
Diversified chemical companies are roiled by raw material cost pressure and the damaging effects of trade tensions between Washington and Beijing.
Albemarle (ALB) Shares Up 12% YTD: What's Driving the Stock?
by Anindya Barman
Forecast-topping Q4 results and upbeat outlook for 2019 have contributed to the gain in Albemarle's (ALB) shares.
Albemarle Hikes Quarterly Dividend, Boosts Shareholder Value
by Zacks Equity Research
Albemarle (ALB) hikes its quarterly dividend by 10%, marking increase for 25th consecutive year.
Company News For Feb 22, 2019
by Zacks Equity Research
Companies In The News Are: CAR,DPZ,ALB,SAM
Albemarle (ALB) in Focus: Stock Moves 7.8% Higher
by Zacks Equity Research
Albemarle (ALB) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
Lithium ETF at One-Month High: Here's Why
by Sanghamitra Saha
Inside the reasons that kept pushing lithium ETF higher this year.
Albemarle's (ALB) Earnings & Sales Trounce Estimates in Q4
by Anindya Barman
Higher sales volumes and favorable pricing drove Albemarle's (ALB) results in Q4. The company provided an upbeat outlook for 2019.
Albemarle (ALB) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Albemarle (ALB) delivered earnings and revenue surprises of 4.79% and 3.57%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Can Albemarle (ALB) Maintain Earnings Beat Streak in Q4?
by Anindya Barman
Albemarle (ALB) will likely gain from higher expected volumes and pricing in its lithium business in Q4.
Albemarle (ALB) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Albemarle (ALB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Albemarle (ALB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Albemarle (ALB) closed at $80.86 in the latest trading session, marking a -0.19% move from the prior day.
Albemarle Initiates Earthworks at Kemerton Lithium Site
by Zacks Equity Research
Albemarle's (ALB) site earthworks at Kemerton are on track and highlights commitment to develop LiOH operations in Western Australia.
US Chemical Industry Rebounds in November As Output Rises
by Anindya Barman
U.S. Chemical production went up across all regions in November barring the Gulf Coast.
Albemarle Enters Oversold Territory
by Zacks Equity Research
Albemarle Corpora has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Albemarle & Mineral Resources Ink Deal to Form Lithium JV
by Zacks Equity Research
The JV formed by Albemarle (ALB) and Mineral Resources will own and operate the Wodgina project as well as produce spodumene concentrate and battery grade lithium hydroxide.
Albemarle (ALB) Well Placed on Lithium Expansion Actions
by Zacks Equity Research
Albemarle (ALB) to gain from strength in the lithium business and expansion actions.
Chemicals Start Q4 on Soft Note with Sluggish October Growth
by Anindya Barman
Global chemical production rose a paltry 0.1% in October following flat growth a month ago.
Why Is Albemarle (ALB) Down 13.9% Since Last Earnings Report?
by Zacks Equity Research
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Should You Add Albemarle (ALB) Stock to Your Portfolio?
by Anindya Barman
Let's see why Albemarle (ALB) stock is worth buying right now.
Albemarle (ALB) Inks Exclusivity Deal with Mineral Resources
by Zacks Equity Research
Albemarle (ALB) has agreed to pay $1.15 billion for a 50% interest in the proposed JV.